去年这个时候，人们还在争论诺和诺德(NVO.US)的Wegovy和礼来(LLY.US)的Zepbound是减肥的捷径还是医学上的突破。但是，随着大量数据表明这些药物的健康益处不仅仅是减少肥胖——包括减轻心脏病、糖尿病、慢性肾病和睡眠呼吸暂停——大多数 ...

10月30日，医药巨头礼来公司的减肥药Zepbound在中国正式上市了！这一消息一出，顿时让无数想要减重的朋友们兴奋不已，甚至有人直呼“这是减肥界的黑科技，快让我来试试！”说到减肥，大家心里都曾有过懊恼吧？那种想穿上美美衣服，却一看到镜子又忍不住叹气的心情，太能共鸣了。

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

通过降低体重，改善阻塞性睡眠呼吸暂停 ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...

你是否在夜间常常感到呼吸困难，或是听到身边的人打鼾声不断？这可能是阻塞性睡眠呼吸暂停（OSA）的表现，而最新的消息显示，FDA已批准礼来公司的减肥药物Zepbound用于治疗这种常见但被广泛误解的睡眠障碍。这一突破性的进展，将对数以亿计的患者产生深远的影响。 阻塞性睡眠呼吸暂停的患者在睡梦中可能会因呼吸道受到阻塞而短暂停止呼吸，这不仅影响睡眠质量，还可能引发心脏病等其他严重健康问题。根据研究，全球 ...

财联社12月20日讯（编辑 牛占林）美东时间周四，美国食品和药品管理局(FDA)发布消息称，礼来公司的畅销减肥药Zepbound已经不再短缺，这将对数十亿美元的复方药市场产生严重冲击。消息发布后，美国远程医疗公司Hims & Hers ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...

The Broadway icon said he’s a “great believer” in the weight-loss medication, which helped him after he weighed 310 lbs.

Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and ...